With a longstanding digital mindset, Celerion is on a journey to implement new clinical research technologies to conduct trials faster and more reliably. They want to get data to clients faster, while making it easier for participants to take part in studies. Celerion recognized early on that electronic Consent (eConsent) would increase efficiency and improve the participant experience. However, previous eConsent solutions had been unable to meet the needs of Phase I studies, which must consent and process large volumes of participants, quickly. Veeva eConsent offers Celerion a scalable solution for their fast-paced environment. Easy-to-use editor tools allow Celerion to create pre-approved consent templates that can be quickly adapted for specific study.

Join for free to read